Abstract
A procedure was developed for preparing [18F]-5-hydroxy-2-fluoro-L-thyrosine ([18F]-fluoro-L-dihydroxyphenylalanine, [18F]-L-DOPA) radiopharmaceutical on modified commercially available GE Tracer-LAB Fx F-E platform. This modification can be used for preparing both [18F]-L-DOPA and any other radiopharmaceuticals by electrophilic radiofluorination. The procedure allows preparation of the product meeting all the requirements of European Pharmacopoeia (8th ed.) for clinical use with the decay-corrected radiochemical yield of 20 ± 3% (n = 3).
Similar content being viewed by others
References
Fanti, S., Farsad, M., and Mansi, L., PET-CT Beyond FDG: A Quick Guide to Image Interpretation, Berlin: Springer, 2010, p. 243.
Orlovskaya, V.V., Fedorova, O.S., and Krasikova, R.N., Russ. Chem. Bull., 2015, vol. 64, no. 7, pp. 1518–1535.
Pretze, M., Wängler, C., and Wängler, B., Biomed. Res. Int., 2014, p. 674 063.
Edwards, R. and Wirth, T., J. Label. Compd. Radiopharm., 2015, vol. 58, no. 5, pp. 183–225.
Namavari, M., Bishop, A., Satyamurthy, N., et al., Int. J. Appl. Radiat. Isot., 1992, vol. 43, no. 8, pp. 989–996.
De Vries, E.F.J., Luurtsema, G., Brüssermann, M., et al., Appl. Radiat. Isot., 1999, vol. 51, no. 4, pp. 389–394.
Forsback, S., Eskola, O., Haaparana, M., et al., Radiochim. Acta., 2008, vol. 96, no. 12, pp. 845–848.
Forsback, S., Eskola, O., Bergman, J., et al., J. Label. Compd. Radiopharm., 2009, vol. 52, no. 7, pp. 286–288.
European Pharmacopoeia, Strasbourg: Council of Europe, 8th ed., vol. 1, pp. 1056–1058.
OFS (General Pharmacopoeia Monograph) 1.1.0008.15: Residual Organic Solvents.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.O. Antuganov, M.P. Zykov, D.V. Ryzhkova, T.A. Zykova, A.A. Vinal’ev, Yu.O. Antuganova, O.P. Samburov, 2016, published in Radiokhimiya, 2016, Vol. 58, No. 6, pp. 556–560.
Rights and permissions
About this article
Cite this article
Antuganov, D.O., Zykov, M.P., Ryzhkova, D.V. et al. Synthesis of [18F]-L-DOPA radiopharmaceutical on a modified GE TracerLAB Fx F-E platform. Radiochemistry 58, 649–653 (2016). https://doi.org/10.1134/S1066362216060138
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362216060138